Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
This study aimed at producing an updated assessment of the incidence of anaphylaxis associated with COVID-19 vaccines based on pharmacovigilance data. Anaphylactic reaction and anaphylactic shock data post-COVID-19-vaccination reported from week 52, 2020 to week 1 or week 2, 2023 were collected from...
Main Authors: | Fotini Boufidou, Sophia Hatziantoniou, Kalliopi Theodoridou, Helena C. Maltezou, Konstantinos Vasileiou, Cleo Anastassopoulou, Snežana Medić, Athanasios Tsakris |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/3/613 |
Similar Items
-
Anaphylactic shock during SpaceOAR Vue hydrogel procedure
by: Lauren Nesi, et al.
Published: (2024-11-01) -
Challenges in diagnosing polyethylene glycol and polysorbate 80 allergies: implications for allergic reactions in COVID-19 mRNA vaccination program: experience from Qatar
by: Sami Aqel, et al.
Published: (2025-01-01) -
Evaluation of Patients with Vaccine Allergies Prior to mRNA-Based COVID-19 Vaccination
by: Xin Rong Lim, et al.
Published: (2022-06-01) -
Anaphylactic reaction as an etiology of ischemic stroke: A case report
by: Rakhmad Hidayat, et al.
Published: (2023-12-01) -
Canada’s First Joint Oncology-Allergy Clinic: Successful Desensitization to Trastuzumab Following Severe Anaphylactic Reaction in Which Epinephrine Was Inappropriately Withheld
by: Madeline Robinson, et al.
Published: (2023-02-01)